Trial Search Results

Automatic Chlorination and Child Health in Urban Bangladesh

Municipal water networks within industrialized countries typically rely on centralized treatment to manage piped water quality. Optimal water quality at the tap, however, requires well-maintained piped distribution networks, and performs best when piped systems are fully pressurized. In low-income cities such as Dhaka, water distribution networks are inadequately maintained and typically supply intermittent service; as such, they are vulnerable to recontamination during negative pressure events. Among populations accessing these types of improved water sources in urban settings (e.g. shared taps), it is unknown if consistent treatment to provide chlorinated water at the point of collection would have a significant health benefit. Furthermore, almost all previous studies of water treatment interventions in low-income countries have been unblinded with self-reported diarrhea as the main outcome, casting doubt that reported impacts of water disinfection on diarrhea are not due entirely to social desirability bias. Stanford University in collaboration with icddr,b will conduct a randomized evaluation to assess the impact on access to automatically chlorinated water on water quality and child health.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: International Centre for Diarrhoeal Disease Research, Bangladesh

Stanford Investigator(s):

Intervention(s):

  • Device: Water chlorination by the Flogenic
  • Device: Active control, vitamin C dosing into water

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Households with at least one child under 60 months old

   - Households using enrolled shared water point as primary drinking water source

Exclusion Criteria:

   - Households with a private drinking water source

Note: New births and children under 60 months that migrate into compounds accessing the
enrolled water points for drinking water will be enrolled into the study.

Ages Eligible for Study

N/A - 60 Months

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Amy Pickering, PhD
510-410-2666
Recruiting